Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Association of cannabis use with opioid outcomes among opioid-dependent youth.

OBJECTIVE: Cannabis use is common among opioid-dependent patients, but studies of its association with treatment outcome are mixed. In this secondary analysis, the association of cannabis use with opioid treatment outcome is assessed. METHODS: In the main study, participants (n=152) aged 15-21 years were randomized to receive psychosocial treatments and either a 12-week course of buprenorphine-naloxone with a dose taper to zero in weeks 9-12, or a 2-week detoxification with buprenorphine-naloxone. Drug use was assessed by self-report and urine drug screen at baseline and during study weeks 1-12. The association between cannabis and opioid use at weeks 4, 8, and 12 was examined using logistic regression models. RESULTS: Participants reported a median of 3.0 days (range=0-30) cannabis use in the past month; half (50.3%; n=77) reported occasional use, one-third reported no use (33.1%; n=50), and one-sixth reported daily cannabis use (16.6%; n=25). Median lifetime cannabis use was 4.0 years (range=0-11) and median age of initiation of use was 15.0 years (range 9-21). Neither past cannabis use (age of initiation and use in the month prior to baseline) nor concurrent use was associated with level of opioid use. CONCLUSIONS: Overall, cannabis use had no association with opioid use over 12 weeks in this sample of opioid-dependent youth. While cannabis use remains potentially harmful, it was not a predictor of poor opioid treatment outcome.

Pubmed ID: 23528523


  • Hill KP
  • Bennett HE
  • Griffin ML
  • Connery HS
  • Fitzmaurice GM
  • Subramaniam G
  • Woody GE
  • Weiss RD


Drug and alcohol dependence

Publication Data

September 1, 2013

Associated Grants

  • Agency: NIDA NIH HHS, Id: CTN U10 DA15831
  • Agency: NIDA NIH HHS, Id: K24 DA022288
  • Agency: NIDA NIH HHS, Id: K24 DA022288
  • Agency: NIDA NIH HHS, Id: K99 DA029115
  • Agency: NIDA NIH HHS, Id: K99/R00 DA029115
  • Agency: NIDA NIH HHS, Id: R00 DA029115
  • Agency: NIDA NIH HHS, Id: U10 DA013043
  • Agency: NIDA NIH HHS, Id: U10 DA015831

Mesh Terms

  • Adult
  • Buprenorphine
  • Data Interpretation, Statistical
  • Female
  • Humans
  • Logistic Models
  • Male
  • Marijuana Abuse
  • Naloxone
  • Narcotic Antagonists
  • Narcotics
  • Opioid-Related Disorders
  • Substance Abuse Detection
  • Treatment Outcome
  • Young Adult